Daiwa Securities has lowered Tigermed’s rating to Outperform from Buy, while leaving its HK$44 price target unchanged, according to ETNet.

The brokerage says Tigermed’s first-half results met market expectations, but net profit missed forecasts due to investment losses that were larger than anticipated. Gross margin was pressured by pricing headwinds as more low-priced legacy projects were included in executed orders.

Daiwa notes that new order growth has accelerated and the average selling price of new orders continues to rise. Management expects pricing on executed orders to stabilise in the second half of 2026, with further improvements anticipated in the first half of 2027.

Additionally, the broker cut its 2027-28 adjusted net profit forecasts for Tigermed by 8% to 10%, citing more conservative gross-margin assumptions and higher research and development spending.

Daiwa Securities said UBTech Robotics (09880) delivered first-half results significantly above market expectations, according to ETNet.

The broker expects broader commercialization in the second half of 2026, with management guiding faster production and deliveries in the same period as industrial deployments expand among customers in automotive, electronics, semiconductors, logistics and aviation.

Based on these operating developments, Daiwa maintains a Buy rating on UBTech.

According to Wallstreetcn, Alibaba Cloud's Bailian large-model service platform has reduced the billing price for the Qwen3-VL-Rerank model in the Beijing region. The text-input rate drops from 0.7 to 0.5 per million tokens, while the multimodal-input rate falls from 1.8 to 0.5 per million tokens, with the changes taking effect on August 31, 2026 at 10:13:53 (UTC+8).

Two listed companies showed unusual trading activity at 9:49 a.m., according to ETNet.

Lightron Health (02661) slipped 0.51% to HK$4.87, marking a fresh listing low. The stock's buy-sell ratio was 41:59, and it has fallen for three consecutive sessions, for a total decline of 5.98%.

Baidu (09888) declined 2.91% to HK$93.40, with a buy-sell ratio of 59:41. Its yuan-denominated counter, 89888, fell 2.6% to RMB80.1.

Unisound (09678) rose about 11% to HK$84.8, a one-month high, and traded above its 50-day moving average of HK$76.954, according to ETNet.

The session\'s low was HK$73.2, with 1.5915 million shares changing hands for HK$126 million.

The stock has advanced in two straight sessions, rising about 30.5% over that period.

Active buying and selling stood at 62 to 38, with net active buying of HK$29.56 million. JPMorgan was the largest net passive buyer at HK$2.5274 million, while Goldman Sachs Asia Securities was the largest net passive seller at HK$5.6088 million.

According to ETNet, institutional investors adjusted holdings in several listed companies in late August, including ZTE, Kuaishou, Xiaomi, Da Tong Group, WuXi XDC, Tigermed and Flat Glass Group.

BlackRock reduced its long position in ZTE by 130,000 shares on August 26, 2026, and trimmed holdings in Kuaishou by 580,000 shares and in Xiaomi by 2.38 million shares on the same date.

Protoss Fund lifted its stake in Da Tong Group by 16.5 million shares on August 26, 2026.

Schroders cut its holding in WuXi XDC by 530,000 shares on August 28, 2026, but added 2.28 million shares on August 27, 2026. It also increased its position in Tigermed by 430,000 shares on August 27, 2026.

Shanghai Ningquan Asset Management raised its stake in Flat Glass Group by 780,000 shares on August 26, 2026.

Major shareholders disclosed changes in holdings across a range of Hong Kong listed companies, according to ETNet.

Schroders Plc reduced its stake in WuXi XDC Cayman (02268) by 530,000 shares on August 28, 2026, after adding 2.28 million shares on August 27.

BlackRock, Inc. trimmed holdings in ZTE (00763), Kuaishou-W (01024) and Xiaomi (01810) on August 26, while Taobao China cut its stake in E-House China Enterprise (02048) on August 28.

Other disclosed increases included Thomson Group (00258), Meiya Entertainment (00391), Sun Art Retail Group (00393), Gome Retail (00493), Da Tong Group (00544), Tao Heung Holdings (00573), China High Speed (00658), Asia Allied Infrastructure (00679), China Smarter Energy (00681), Hong Kong Technology Venture (01137), Comba Telecom Systems (01473), China Smartpay Group (01796), Hengan International (01882), Comtec Solar Systems Group (01912), Xunlei Cloud (02392), Tigermed (03347), VStecs Holdings (03393), Henry Group Holdings (03638), Flat Glass Group (06865) and Zhong An Holdings (08462).

Hong Kong Exchanges and Clearing (HKEX) published the top 10 most active Southbound stocks through the Shanghai and Shenzhen links on July 31, according to ETNet. The list comprises Zhipu (02513), MiniMax (00100), Kingboard Laminates (01888), Yangtze Optical Fibre and Cable (06869), China Construction Bank (00939), Tencent (00700), SMIC (00981), Alibaba (09988), Meituan (03690) and ICBC (01398).

Shanghai link: Zhipu posted net selling of HK$858.10 million, and MiniMax posted net selling of HK$524.59 million. Meituan recorded net buying of HK$334.44 million, while Tencent saw net buying of HK$182.54 million. China Construction Bank registered net selling of HK$1.03 billion.

Shenzhen link: Meituan registered net selling of HK$1.19 billion, and Tencent posted net buying of HK$229.09 million. MiniMax posted net buying of HK$115.41 million, and Kingboard Laminates posted net buying of HK$145.72 million. Additional names among the most active in Shenzhen included Hua Hong Semiconductor (01347), WuXi Biologics (02269) and Shandong Gold Mining (01787).

The head of the Bank for International Settlements, Pablo Hernández de Cos, warned on August 28 that stablecoins could raise borrowing costs as banks broaden their activities in digital money, potentially squeezing banks’ deposit bases and driving the development of new products.

Federal Reserve researchers view these tokens as possible rivals to traditional transaction accounts.

The discussion notes ongoing industry efforts, including JPM Coin from JPMorgan Chase, CoinVertible from Société Générale‑FORGE, and a planned euro-stablecoin from Qivalis.

A federal jury ruled in favor of Reckitt Benckiser's Mead Johnson unit in the first bellwether trial over allegations that its infant formula for premature babies is linked to a deadly bowel disease.

The case is part of a federal multidistrict litigation comprising lawsuits accusing the product of causing the illness.